SG11201804029UA - Prophylactic and/or therapeutic agent for nafld/nash - Google Patents

Prophylactic and/or therapeutic agent for nafld/nash

Info

Publication number
SG11201804029UA
SG11201804029UA SG11201804029UA SG11201804029UA SG11201804029UA SG 11201804029U A SG11201804029U A SG 11201804029UA SG 11201804029U A SG11201804029U A SG 11201804029UA SG 11201804029U A SG11201804029U A SG 11201804029UA SG 11201804029U A SG11201804029U A SG 11201804029UA
Authority
SG
Singapore
Prior art keywords
prophylactic
nafld
nash
therapeutic agent
processed product
Prior art date
Application number
SG11201804029UA
Inventor
Katsuya Hiraishi
Fumie Jimma
Hiroyuki Soma
Taro Adachi
Masakazu Adachi
Ippei Yamaoka
Tomohiro Kagawa
Original Assignee
Adabio Co Ltd
Otsuka Pharma Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adabio Co Ltd, Otsuka Pharma Factory Inc filed Critical Adabio Co Ltd
Publication of SG11201804029UA publication Critical patent/SG11201804029UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health

Abstract

PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR NAFLD/NASH The present invention provides a prophylactic and/or therapeutic agent for non-alcoholic fatty liver disease (NAFLD), and particularly non-alcoholic steatohepatitis (NASH) comprising an ume (Japanese apricot) juice concentrate or a processed product thereof. The prophylactic and/or therapeutic agent is obtained by utilizing a component contained in a plant or a processed product thereof, and hence is safe and easily taken. It has been confirmed that when the ume juice concentrate or the processed product thereof is orally administered to a streptozocin (STZ)-induced NAFLD model mouse or an STZ- induced NASH model mouse, liver fibrogenesis can be reduced. [Figure 8]
SG11201804029UA 2015-11-27 2016-11-25 Prophylactic and/or therapeutic agent for nafld/nash SG11201804029UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015232053 2015-11-27
PCT/JP2016/004963 WO2017090253A1 (en) 2015-11-27 2016-11-25 Prophylactic and/or therapeutic agent for nafld/nash

Publications (1)

Publication Number Publication Date
SG11201804029UA true SG11201804029UA (en) 2018-06-28

Family

ID=58763356

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201804029UA SG11201804029UA (en) 2015-11-27 2016-11-25 Prophylactic and/or therapeutic agent for nafld/nash

Country Status (12)

Country Link
US (1) US10610558B2 (en)
EP (1) EP3381459A4 (en)
JP (1) JP6485846B2 (en)
KR (1) KR102080128B1 (en)
CN (1) CN108289923A (en)
AU (1) AU2016359870B2 (en)
CA (1) CA3004153A1 (en)
NZ (1) NZ742338A (en)
PH (1) PH12018550050A1 (en)
SG (1) SG11201804029UA (en)
TW (1) TW201722455A (en)
WO (1) WO2017090253A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100396590B1 (en) * 2001-07-10 2003-09-02 주식회사 신광레포츠 Method for manufacturing arrow shaft
CN114845725B (en) * 2019-12-24 2023-09-26 (株)美尊生活健康 Pharmaceutical composition for preventing or treating non-alcoholic steatohepatitis comprising Aster koraiensis extract

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473426B2 (en) * 2001-02-27 2009-01-06 Yun Seok Choe Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract
JP2003265138A (en) * 2002-03-18 2003-09-24 Nippon Apricot:Kk Antineoplastic beverage and food
JP4842624B2 (en) * 2005-11-25 2011-12-21 Ａｄａ Ｂｉｏ株式会社 Food and drink for autophagy guidance
JP5577129B2 (en) 2010-03-26 2014-08-20 Ａｄａ Ｂｉｏ株式会社 Liver function improving agent in patients with viral hepatitis
KR101245434B1 (en) * 2012-09-28 2013-03-19 김태현 A supporting agent for plant and animal growth
KR101639128B1 (en) * 2013-10-29 2016-07-13 울산대학교 산학협력단 Pharmaceutical composition for treating or preventing liver diseases containing plasmalogen precursor, plasmalogen or plasmalogen analogue

Also Published As

Publication number Publication date
JPWO2017090253A1 (en) 2018-07-12
US20180325975A1 (en) 2018-11-15
AU2016359870B2 (en) 2019-10-31
EP3381459A1 (en) 2018-10-03
CA3004153A1 (en) 2017-06-01
AU2016359870A1 (en) 2018-05-24
JP6485846B2 (en) 2019-03-20
KR20180059553A (en) 2018-06-04
CN108289923A (en) 2018-07-17
PH12018550050A1 (en) 2018-10-29
EP3381459A4 (en) 2019-07-24
NZ742338A (en) 2020-01-31
TW201722455A (en) 2017-07-01
WO2017090253A1 (en) 2017-06-01
US10610558B2 (en) 2020-04-07
KR102080128B1 (en) 2020-02-24

Similar Documents

Publication Publication Date Title
MX2021006035A (en) Stable cannabinoid formulations.
WO2016090145A3 (en) Exfoliating cosmetic compositions
PH12018502634A1 (en) Topical compositions of apremilast
ZA202103074B (en) Formulation based on medicinal plant, or part or extract thereof, use of the formulation and product including said formulation
CL2016002955A1 (en) Sweetener composition comprising allulose and a stevia extract; food product or beverage comprising the sweetener composition; tabletop sweetener; use of the sweetener composition.
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
PH12017500641A1 (en) Nutritional compositions comprising an oxidizablecomponent and water-soluble plant extract
SG10201806854XA (en) Compositions comprising 15-ohepa and methods of using the same
MX2016013575A (en) Composition for preventing or treating fatty liver diseases.
MX2016016995A (en) Composition containing phytic acid, magnesium and polyphenols for the treatment or prevention of renal lithiasis.
MY177974A (en) A pharmaceutical composition for prevention of diet induced obesity
SG11201804029UA (en) Prophylactic and/or therapeutic agent for nafld/nash
WO2015140748A3 (en) Sildenafil solutions and methods of making and using same
NZ713235A (en) Product and method for improving bioavailability of therapeutic compounds
MX369122B (en) Herbal supplements and methods of use thereof.
GB201307973D0 (en) Extracts of cynanchum SP.and active ingredients contained therein in use of arthritis treatment
WO2016114621A3 (en) Composition for prevention or treatment of metabolic bone diseases comprising combined extract of schisandra chinesis, eucommiae cortex and lycium chinense as active ingredient
WO2018078599A3 (en) Composition for the preventive or curative treatment of liver disorders
MY175298A (en) Extract of greyia radlkoferi and use thereof
MX2019013493A (en) Composition for enhanced absorption of supplements.
PH12016501553A1 (en) Metadoxine for use in the treatment of liver diseases, and metadoxine extended release formulations
Kanno Neutropenia and hair loss: case report
Creytens Allergic contact dermatitis: case report
Yuan US “Pivot to Asia" Faces Numerous Problems Ahead
EP3366296A4 (en) Methods for using regulators for increasing the expression or activation of p53 and/or regulators for reducing or inhibiting the expression of p63-alpha, for the treatment of non-alcoholic fatty liver disease (nafld) and/or non-alcoholic steatohepatitis (nash)